Video

Single administration of intracameral bimatoprost implant: IOP lowering, safety

Author(s):

David Hutton,Alex Delaney-Gesing
Conferences|AAO

Michael R. Robinson, MD, shares the highlights of the study "Single administration of intracameral bimatoprost implant 10 µg: IOP lowering and safety," presented during the virtual AAO 2020 meeting.

Michael R. Robinson, MD, vice president, Global Therapeutic Area Head, Ophthalmology at Allergan, shares the highlights of the study "Single administration of intracameral bimatoprost implant 10 µg: IOP lowering and safety," presented during the virtual AAO 2020 meeting.

See more AAO coverage here

Related Videos
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
Image credit: ©Ophthalmology Times
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Wendy Lee, MD, talks about functional oculoplastics and aesthetics at EnVision Summit 2025
1 expert is featured in this series.
Lana Rifkin, MD, uveitis committee chair at EnVision Summit 2025
Related Content
Sling Therapeutics announces topline efficacy and safety data from Phase 2b/3 LIDS trial on linsitinib
January 21st 2025

Sling Therapeutics announces topline efficacy and safety data from Phase 2b/3 LIDS trial on linsitinib

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Sight Sciences announces publication of 36-month analysis of OMNI Surgical System in managing primary open-angle glaucoma
January 9th 2025

Sight Sciences announces publication of 36-month analysis of OMNI Surgical System in managing primary open-angle glaucoma

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Prevent Blindness Ohio offers free glaucoma resources to patients and professionals
January 7th 2025

Prevent Blindness Ohio offers free glaucoma resources to patients and professionals

European Medicines Agency to assess semaglutide for link to NAION
January 3rd 2025

European Medicines Agency to assess semaglutide for link to NAION

© 2025 MJH Life Sciences

All rights reserved.